カテゴリ： MarketLine, ドイツ, 企業調査

Lanxess AG：企業の戦略・SWOT・財務情報

◆英語タイトル：Lanxess AG - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3715
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥24,150見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥48,300見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥72,450見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Lanxess AG – Strategy, SWOT and Corporate Finance Report
Summary

Lanxess AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Lanxess AG (Lanxess or ‘the company’) is a leading specialty chemicals company. The company’s product portfolio comprises chlorobenzenes, chlorotoluenes, cresols, nitrotoluenes and their derivatives, amines, benzyl products, hydrofluoric acid, maleic anhydride, hydrazine hydrate, trimethylol propane and hexandiol. It also supplies synthetic rubbers through ARLANXEO, a joint venture with Saudi Aramco. The company’s products find applications in the areas of agrochemicals, automotive, construction, aromas and flavors, pharmaceuticals, tire chemicals, electrical, electronics and medical equipment, leather processing and water treatment, among others. Lanxess operates across Europe, the Middle East and Africa (EMEA), North America, Latin America and Asia-Pacific. Lanxess is headquartered in Cologne, North Rhine-Westphalia, Germany.

Scope

- Detailed information on Lanxess AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Lanxess AG in the form of a SWOT analysis
- An in-depth view of the business model of Lanxess AG including a breakdown and examination of key business segments
- Intelligence on Lanxess AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Lanxess AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Lanxess AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Lanxess AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Lanxess AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Lanxess AG: Company Overview 9
Lanxess AG: Overview and Key Facts 9
Lanxess AG: Overview 9
Lanxess AG: Key Facts 9
Lanxess AG: Key Employees 11
Lanxess AG: Key Employee Biographies 12
Lanxess AG: Major Products and Services 18
Lanxess AG: Company History 19
Lanxess AG: Management Statement 23
Lanxess AG: Key Competitors 24
Lanxess AG: Company Analysis 25
Lanxess AG: Business Description 25
Lanxess AG: SWOT Analysis 27
Lanxess AG: SWOT Overview 27
Lanxess AG: Strengths 27
Lanxess AG: Weaknesses 28
Lanxess AG: Opportunities 28
Lanxess AG: Threats 29
Lanxess AG: Corporate Financial Deals Activity 31
Lanxess AG: Financial Deals Overview 31
Lanxess AG: Targets and Partners 32
Lanxess AG: Top Deals 2014 – 2018YTD* 33
Lanxess AG: Advisors 34
Lanxess AG: Top Legal Advisors 34
Lanxess AG: Mergers and Acquisitions 35
Lanxess AG: Capital Raising 36
Lanxess AG: Partnership 37
Lanxess AG: Divestments 38
Lanxess AG: Private Equity and Ownership 39
Lanxess AG: Recent Developments 40
Lanxess AG: News and Events Summary 40
Lanxess AG: Business Expansion 43
Lanxess AG: Corporate Governance 44
Lanxess AG: Financial Deals 45
Lanxess AG: Strategy and Operations 45
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Lanxess AG: Key Facts
Table 2: Lanxess AG: Key Employees
Table 3: Lanxess AG: Key Competitors
Table 4: Lanxess AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 5: Lanxess AG: M&A Average Deal Size - Value (US$m)
Table 6: Lanxess AG: Targets and Partners
Table 7: Lanxess AG: Top Deals 2014 - 2018YTD*
Table 8: Lanxess AG: Legal Advisor Ranking by Value (US$m)
Table 9: Lanxess AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Lanxess AG: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Lanxess AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: Lanxess AG: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: Lanxess AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Lanxess AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Lanxess AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: Lanxess AG: Divestments by Geography (2014 - YTD*2018)
Table 17: Lanxess AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 18: Lanxess AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 19: Lanxess AG: News and Events Summary
Table 20: Lanxess AG: Business Expansion
Table 21: Lanxess AG: Corporate Governance
Table 22: Lanxess AG: Financial Deals
Table 23: Lanxess AG: Strategy and Operations

List of Figures
Figure 1: Lanxess AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Lanxess AG: M&A Average Deal Size - Value (US$m)
Figure 3: Lanxess AG: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Lanxess AG: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Lanxess AG: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Lanxess AG: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: Lanxess AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Lanxess AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Lanxess AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Lanxess AG: Divestments by Geography (2014 - YTD*2018)
Figure 11: Lanxess AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Lanxess AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Lanxess AG：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Development Center for Biotechnology-製薬・医療分野：企業M&A・提携分析
    Summary Development Center for Biotechnology (DCB) is a non-profit organization that provides support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and devel …
  • Builders FirstSource Inc：企業の戦略・SWOT・財務情報
    Builders FirstSource Inc - Strategy, SWOT and Corporate Finance Report Summary Builders FirstSource Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AnaMar AB：医療機器：M&Aディール及び事業提携情報
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, is a drug discovery company that discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes on the receptors …
  • PMA Companies, Inc.：企業の戦略・SWOT・財務情報
    PMA Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary PMA Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NeuroPace Inc-医療機器分野：企業M&A・提携分析
    Summary NeuroPace Inc (NeuroPace) is a medical device company that designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders. The company’s products include cutting edge medical devices, RNS systems, patient data management systems, magnet products, …
  • Gridsum Holding, Inc. (GSUM)：企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Statkraft AS：企業のM&A・事業提携・投資動向
    Statkraft AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statkraft AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Semiconductor Manufacturing International Corporation：企業の戦略・SWOT・財務分析
    Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report Summary Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • SQI Diagnostics Inc (SQD)：企業の財務・戦略的SWOT分析
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. It provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. I …
  • EXINI Diagnostics AB：医療機器：M&Aディール及び事業提携情報
    Summary EXINI Diagnostics AB (EXINI), a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare technology company that offers development of software solutions for the medical diagnostic market. The company offers aBSI, a web application used by trained healthcare professionals and researchers …
  • Prudential Financial Inc：戦略・SWOT・企業財務分析
    Prudential Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Prudential Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Provectus Biopharmaceuticals Inc (PVCT)-製薬・医療分野：企業M&A・提携分析
    Summary Provectus Biopharmaceuticals Inc (Provectus), formerly Provectus pharmaceuticals Inc is a biotechnology company that develops pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for recurrent melanoma, PV-10 for metastatic liver canc …
  • Instrumentation Laboratory Company-医療機器分野：企業M&A・提携分析
    Summary Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories …
  • National Electric Power Co：企業の戦略的SWOT分析
    National Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Delegat’s Group Limited：企業の戦略・SWOT・財務分析
    Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Oakton Limited：企業の戦略的SWOT分析
    Oakton Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Storebrand ASA：企業のM&A・事業提携・投資動向
    Storebrand ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Storebrand ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Shanghai Institute of Materia Medica Chinese Academy of Sciences-製薬・医療分野：企業M&A・提携分析
    Summary Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that offers research and development of traditional Chinese medicine. The institute provides solutions in the areas of drug discovery and drug development. It also provides studies of …
  • Apoteket AB：企業の戦略的SWOT分析
    Apoteket AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Virgin Australia Holdings Limited：企業のM&A・事業提携・投資動向
    Virgin Australia Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Australia Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆